Alloimmunization commonly affects 2-5% of all transfusion recipients and approximately 30% of chronically transfused patients with sickle-cell disease. Since ABO…
Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
Privacy Policy
